PEGS Boston Conference & Expo

Join us in Boston – we are at booth 302.

Come and see us at PEGS Boston and learn more about Polar, the world’s first BioPharma Lifecycle Management (BPLM) platform, and how it can help your team efficiently execute processes while curating the data you need to accelerate time to market.

Watch our on-demand webinar “Democratizing access to AI/ML-powered insights to accelerate BioPharma process optimization” for tips on creating a more efficient path to process understanding.

Polar is a platform that securely manages drug progression in contexts of workflow, integration and insight.

Michael Barnes will be presenting on Tuesday, May 16, at 10:00 AM EDT. Don’t miss his presentation “Reimagining data management to accelerate time to insight throughout the BioPharma Lifecycle from R&D to manufacturing.”

Despite the promises of Biopharma 4.0, most organizations struggle with tools and platforms that create data silos, integrity risks from manual manipulation, and difficult aligning data for analysis and modelling. Simply digitizing and consolidating data is not enough, unlocking insight requires a different strategy. We discuss how a holistic contextualized data backbone, linked to an advanced analytics engine, can expedite process understanding for faster decisions and efficient knowledge transfer.

We look forward to connecting with you at PEGS Boston!

About PEGS Boston Conference & Expo: The Essential Protein Engineering & Cell Therapy Summit. The world’s largest gathering of protein engineering and biotherapeutics experts, PEGS Boston is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics, immunogenicity and more.

Michael Barnes, Lead Solutions Consultant

Multidisciplinary bench scientist having worked in various roles and companies, from isolating rare and underrepresented cancers at the Broad Institute to automating cell-based toxicology assays in a CRO setting. 

Prior to shifting to IDBS, Michael spent ~3 years in Pfizer’s BioProcess R&D Cell Line Development group, working to evaluate different vectors/expression systems and investigate phenotypic changes at a genotypic level.

Garrett Mullen, Strategic Account Manager

With more than 20 years of experience in the enterprise lab management software business, Garrett has helped a multitude of companies from the BioPharma, Petro-Chemical, specialty chemical, food, medical device industries and more.  

Garrett began his career as a molecular biologist working on the Human Genome Project at Washington University in St. Louis. Since then, he’s held various roles as a lab manager, systems engineer, professional services manager, enterprise software sales, engineering and product marketing positions. 

Garrett holds a BS in Biological Sciences from Illinois State University. 

Shirlee Wallingford, Lead Solutions Consultant

As a Solutions Consultant, Shirlee works with companies to understand their business needs and provide solutions to address their data management challenges. She has over 20 years of experience as a bench scientist in the pharmaceutical industry. She has experience in both GMP and non-GMP settings.  

Prior to joining IDBS, she worked at Allergan/AbbVie where she developed cell-based potency assays.  

Shirlee has a BA in Biochemistry from Pomona College, Claremont, and an M.Ed. from UCLA.